+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen



Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen



Chest 85(1): 6-14



Some patients with chronic obstructive pulmonary disease (COPD) experience transient arterial hypoxemia (TAH) during rapid eye movement (REM) sleep. To examine the effect of short- and long-term low flow oxygen on TAH associated cardiopulmonary hemodynamics, we recorded pulmonary artery pressure (Ppa) and cardiac output during nocturnal sleep in seven male subjects with COPD. In all of the subjects, parameters were measured breathing room air at baseline time and after eight or more weeks of home supplemental oxygen (15 hours per day, 3 L/min). Five were also studied one full night at baseline time while breathing 3 L/min nasal oxygen. While breathing room air both before and after chronic home oxygen therapy, transient increases in Ppa during TAH were due to increased pulmonary vascular resistance in seven instances, increased cardiac output in four, and increases in both vascular resistance and cardiac output in two. Short-term supplemental oxygen lowered mean sleeping Ppa and eliminated TAH along with its associated hemodynamic changes in four of the five subjects; the fifth did not experience REM sleep. In the six subjects who complied with the eight-week home oxygen protocol, mean sleeping Ppa was significantly reduced (p less than 0.05). In four of these, total pulmonary resistance was lower and cardiac output higher after home oxygen therapy. Short-term supplemental oxygen is useful in correcting REM-associated TAH and in some hypoxemic subjects, reducing mean sleeping Ppa. Sustained reductions in pulmonary vascular resistance after long-term home oxygen therapy may be indicative of improved cardiac and pulmonary vascular status even in subjects showing minimal or no reduction in mean sleeping Ppa.

(PDF emailed within 1 workday: $29.90)

Accession: 042452012

Download citation: RISBibTeXText

PMID: 6690253


Related references

Cardiopulmonary Hemodynamics during Sleep in Subjects with Chronic Obstructive Pulmonary Disease. Chest Journal 85(1): 6-14, 1984

Smell and taste function in subjects with chronic obstructive pulmonary disease. Effect of long-term oxygen via nasal cannulas. Chest 97(3): 595-599, 1990

Effect of supplemental oxygen during sleep in subjects with sleep apnea and chronic obstructive pulmonary disease. American Review of Respiratory Disease 127(4 PART 2): 128, 1983

Cardiopulmonary improvement by combination of long-term oxygen therapy and nitric oxide inhalation in chronic obstructive pulmonary disease. Anesthesiology 83(3A): A202, 1995

Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration; International Review of Thoracic Diseases 61(1): 8-13, 1994

The effect of short-term oxygen supplementation on oxygen hemoglobin affinity in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease 131(1): 69-72, 1985

Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease 146(3): 665-669, 1992

The Long-Term Oxygen Trial, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome, and Collaborative Management of Sleep Disorders. American Journal of Respiratory and Critical Care Medicine 195(10): 1394-1396, 2017

Short- and long-term effects of ambient ozone and fine particulate matter on the respiratory health of chronic obstructive pulmonary disease subjects. Archives of Environmental and Occupational Health 70(1): 56-62, 2015

Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 12(12): 1796-1804, 2016

Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study. Respiratory Medicine 97(12): 1303-1312, 2003

Long term course of pulmonary hemodynamics in chronic obstructive pulmonary disease. Widimsky, J , J Herget And J Mlczoch (Ed ) Progress in Respiration Research, Vol 20 Pulmonary Circulation in Chronic Lung Diseases: Experimental And Clinical Approach; Meeting, Prague, Czechoslovakia, July 4-6, 1984 Vii+192p S Karger: Basel, Switzerland; New York, N Y , Usa Illus 150-156, 1985

Therapeutic effect of ipratropium bromide plus fenoterol in short and long term chronic obstructive pulmonary disease. Clinical Respiratory Physiology 23(SUPPL 10): 126S, 1987

Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. European Neurology 42(1): 27-35, 1999

Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 52(8): 674-679, 1997